Silent corticotroph adenomas. 2018

Anat Ben-Shlomo, and Odelia Cooper
Pituitary Center, Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, 127 S. San Vicente Blvd, A6600, Los Angeles, CA, 90048, USA.

OBJECTIVE Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for adrenocorticotrophic hormone (ACTH) without biochemical and clinical manifestation of hypercortisolism. Pathologic examination of resected NFAs that demonstrate positive ACTH and/or TPIT expression confirms its corticotroph lineage. SCAs comprise up to 20% of NFAs and exhibit a higher rate of recurrence. Studies of molecular mechanisms have generated multiple hypotheses on SCA tumorigenesis, pathophysiology, and growth that as yet remain to be proven. An improved understanding of their pathologic and clinical characteristics is needed. METHODS A literature review was performed using PubMed to identify research reports and clinical case series on SCAs. RESULTS Up to date findings regarding epidemiology, mechanisms of pathogenesis, differentiation, progression, and growth, as well as clinical presentation, postoperative course, and treatment options for patients with SCAs are presented. Pooled results demonstrate that 25-40% of cases show cavernous sinus invasion, preoperative hypopituitarism, new-onset hypopituitarism, and recurrence. CONCLUSIONS This article reviews the incidence, molecular pathology, and clinical behavior of these unique non-functioning pituitary corticotroph adenomas, and highlights the need for rigorous monitoring for recurrences and hypopituitarism in patients with SCAs.

UI MeSH Term Description Entries
D008297 Male Males
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D049913 ACTH-Secreting Pituitary Adenoma A pituitary adenoma which secretes ADRENOCORTICOTROPIN, leading to CUSHING DISEASE. Corticotroph Adenoma,Pituitary Adenoma, ACTH-Secreting,Pituitary Corticotropin-Secreting Adenoma,ACTH-Producing Pituitary Adenoma,ACTH Producing Pituitary Adenoma,ACTH Secreting Pituitary Adenoma,ACTH-Producing Pituitary Adenomas,ACTH-Secreting Pituitary Adenomas,Adenoma, Corticotroph,Adenomas, Corticotroph,Corticotroph Adenomas,Corticotropin-Secreting Adenoma, Pituitary,Corticotropin-Secreting Adenomas, Pituitary,Pituitary Adenoma, ACTH Secreting,Pituitary Adenoma, ACTH-Producing,Pituitary Adenomas, ACTH-Producing,Pituitary Adenomas, ACTH-Secreting,Pituitary Corticotropin Secreting Adenoma,Pituitary Corticotropin-Secreting Adenomas

Related Publications

Anat Ben-Shlomo, and Odelia Cooper
April 2015, Pituitary,
Anat Ben-Shlomo, and Odelia Cooper
November 2007, Arquivos brasileiros de endocrinologia e metabologia,
Anat Ben-Shlomo, and Odelia Cooper
August 2012, Acta neurochirurgica,
Anat Ben-Shlomo, and Odelia Cooper
June 2021, Medicina clinica,
Anat Ben-Shlomo, and Odelia Cooper
September 2004, Human pathology,
Anat Ben-Shlomo, and Odelia Cooper
February 2005, British journal of neurosurgery,
Anat Ben-Shlomo, and Odelia Cooper
May 2022, World neurosurgery,
Anat Ben-Shlomo, and Odelia Cooper
November 2014, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!